Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Immortalization of osteoclast precursors by targeting Bcl -XL and Simian virus 40 large T antigen to the osteoclast lineage in transgenic mice.
T A Hentunen, … , J J Windle, G D Roodman
T A Hentunen, … , J J Windle, G D Roodman
Published July 1, 1998
Citation Information: J Clin Invest. 1998;102(1):88-97. https://doi.org/10.1172/JCI2004.
View: Text | PDF
Research Article Article has an altmetric score of 3

Immortalization of osteoclast precursors by targeting Bcl -XL and Simian virus 40 large T antigen to the osteoclast lineage in transgenic mice.

  • Text
  • PDF
Abstract

Cellular and molecular characterization of osteoclasts (OCL) has been extremely difficult since OCL are rare cells, and are difficult to isolate in large numbers. We used the tartrate-resistant acid phosphatase promoter to target the bcl-XL and/or Simian Virus 40 large T antigen (Tag) genes to cells in the OCL lineage in transgenic mice as a means of immortalizing OCL precursors. Immunocytochemical studies confirmed that we had targeted Bcl-XL and/or Tag to OCL, and transformed and mitotic OCL were readily apparent in bones from both Tag and bcl-XL/Tag mice. OCL formation in primary bone marrow cultures from bcl-XL, Tag, or bcl-XL/Tag mice was twofold greater compared with that of nontransgenic littermates. Bone marrow cells from bcl-XL/Tag mice, but not from singly transgenic bcl-XL or Tag mice, have survived in continuous culture for more than a year. These cells form high numbers of bone-resorbing OCL when cultured using standard conditions for inducing OCL formation, with approximately 50% of the mononuclear cells incorporated into OCL. The OCL that form express calcitonin receptors and contract in response to calcitonin. Studies examining the proliferative capacity and the resistance of OCL precursors from these transgenic mice to apoptosis demonstrated that the increased numbers of OCL precursors in marrow from bcl-XL/Tag mice was due to their increased survival rather than an increased proliferative capacity compared with Tag, bcl-XL, or normal mice. Histomorphometric studies of bones from bcl-XL/Tag mice also confirmed that there were increased numbers of OCL precursors (TRAP + mononuclear cells) present in vivo. These data demonstrate that by targeting both bcl-XL and Tag to cells in the OCL lineage, we have immortalized OCL precursors that form bone-resorbing OCL with an efficiency that is 300-500 times greater than that of normal marrow.

Authors

T A Hentunen, S V Reddy, B F Boyce, R Devlin, H R Park, H Chung, K S Selander, M Dallas, N Kurihara, D L Galson, S R Goldring, B A Koop, J J Windle, G D Roodman

×

Total citations by year

Year: 2019 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 Total
Citations: 1 1 8 4 4 2 1 3 3 1 4 2 1 6 4 1 46
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (46)

Title and authors Publication Year
Positive and negative regulators of osteoclast apoptosis
NS Soysa, N Alles
Bone Reports 2019
FoxO1 Orchestrates the Bone Suppressing Function of Gut Serotonin
Aruna Kode, Ioanna Mosialou, Barbara C Silva, Marie-Therese Rached, Bin Zhou, Ji Wang, Tim Townes, Rene Hen, Ronald DePinho, Edward Guo, Stavroula Kousteni
Journal of Clinical Investigation 2012
Bone Research Protocols
MH Helfrich, SH Ralston
2011
Bone Research Protocols
MH Helfrich, SH Ralston
2011
Bone Research Protocols
MH Helfrich, SH Ralston
2011
Bone Research Protocols
MH Helfrich, SH Ralston
2011
Bone Research Protocols
MH Helfrich, SH Ralston
2011
Bone Research Protocols
MH Helfrich, SH Ralston
2011
Bim: Guardian of Tissue Homeostasis and Critical Regulator of the Immune System, Tumorigenesis and Bone Biology
T Akiyama, S Tanaka
Archivum Immunologiae et Therapiae Experimentalis 2011
Osteoclasts derived from patients with neurofibromatosis 1 (NF1) display insensitivity to bisphosphonates in vitro
E Heervä, S Peltonen, E Svedström, HT Aro, K Väänänen, J Peltonen
Bone 2011
Activating Transcription Factor 4 Regulates Osteoclast Differentiation
Huiling Cao, Shibing Yu, Zhi Yao, Deborah L. Galson, Yu Jiang, Xiaoyan Zhang, Jie Fan, Binfeng Lu, Youfei Guan, Min Luo, Yumei Lai, Yibei Zhu, Noriyoshi Kurihara, Kenneth Patrene, G. David Roodman, Guozhi Xiao
Journal of Clinical Investigation 2010
Genetic alterations in a telomerase-immortalized human esophageal epithelial cell line: Implications for carcinogenesis
PY Cheung, W Deng, C Man, WW Tse, G Srivastava, S Law, SW Tsao, AL Cheung
Cancer Letters 2010
ADAM8 Enhances Osteoclast Precursor Fusion and Osteoclast Formation In Vitro and In Vivo
H Ishizuka, V García-Palacios, G Lu, MA Subler, H Zhang, CS Boykin, SJ Choi, L Zhao, K Patrene, DL Galson, HC Blair, TM Hadi, JJ Windle, N Kurihara, GD Roodman
Journal of Bone and Mineral Research 2010
Vitamins & Hormones
KJ Hare, FK Knop
Vitamins & Hormones 2010
Negative regulation of bone-resorbing activity of osteoclasts by anti-apoptotic Bcl-xL protein
Mitsuyasu Iwasawa, Tsuyoshi Miyazaki, Yuichi Nagase, Toru Akiyama, Yuho Kadono, Masaki Nakamura, yasushi Oshima, Tetsuro Yasui, Takashi Nakamura, Shigeaki Kato, Lothar Hennighausen, Kozo Nakamura, Sakae Tanaka, Takumi Matsumoto
Journal of Clinical Investigation 2009
The Osteoblast, a Novel Site of Action for FoxO1 Regulation of Glucose Homeostasis
Marie-Therese Rached, Aruna Kode, Barbara C Silva, Dae Young Jung, Susan J Gray, Helena Ong, Ji-Hye Paik, Ronald A DePinho, Jason Kim, Gerard Karsenty, Stavroula Kousteni
Journal of Clinical Investigation 2009
Rac1 and Rac2 in Osteoclastogenesis: A Cell Immortalization Model
Y Wang, DD Belsham, M Glogauer
Calcified Tissue International 2009
Expression of macrophage inhibitory cytokine-1 in prostate cancer bone metastases induces osteoclast activation and weight loss
S Wakchoure, TM Swain, TA Hentunen, AR Bauskin, DA Brown, SN Breit, KS Vuopala, KW Harris, KS Selander
The Prostate 2009
Human osteoclasts differentiated from umbilical cord blood precursors are less prone to apoptotic stimuli than osteoclasts from peripheral blood
L Penolazzi, B Pocaterra, E Tavanti, E Lambertini, F Vesce, R Gambari, R Piva
Apoptosis 2008
Principles of Bone Biology
CJ Rosen, T Niu
Principles of Bone Biology 2008
Signaling Axis in Osteoclast Biology and Therapeutic Targeting in the RANKL/RANK/OPG System
S Tanaka
American Journal of Nephrology 2007
Bone Marrow Cell Differentiation Induced by Mechanically Damaged Osteocytes in 3D Gel-Embedded Culture
K Kurata, TJ Heino, H Higaki, HK Väänänen
Journal of Bone and Mineral Research 2006
Regulation of Osteoclast Differentiation
GD Roodman
Annals of the New York Academy of Sciences 2006
Molecular Mechanism of the Life and Death of the Osteoclast
S Tanaka
Annals of the New York Academy of Sciences 2006
Tumor necrosis factor prevents alendronate-induced osteoclast apoptosis in vivo by stimulating Bcl-xL expression through Ets-2
Q Zhang, IR Badell, EM Schwarz, KE Boulukos, Z Yao, BF Boyce, L Xing
Arthritis & Rheumatism 2005
Regulation of apoptosis in osteoclasts and osteoblastic cells
L Xing, BF Boyce
Biochemical and Biophysical Research Communications 2005
Role of RANKL in physiological and pathological bone resorption and therapeutics targeting the RANKL-RANK signaling system
S Tanaka, K Nakamura, N Takahasi, T Suda
Immunological Reviews 2005
IL-3 expression by myeloma cells increases both osteoclast formation and growth of myeloma cells
JW Lee, HY Chung, LA Ehrlich, DF Jelinek, NS Callander, GD Roodman, SJ Choi
Blood 2004
M-CSF, TNFalpha and RANK ligand promote osteoclast survival by signaling through mTOR/S6 kinase
H Glantschnig, JE Fisher, G Wesolowski, GA Rodan, AA Reszka
Cell Death and Differentiation 2003
Bcl-xL overexpression blocks bax-mediated mitochondrial contact site formation and apoptosis in rod photoreceptors of lead-exposed mice
L He, GA Perkins, AT Poblenz, JB Harris, M Hung, MH Ellisman, DA Fox
Proceedings of the National Academy of Sciences 2003
Eosinophil Chemotactic Factor-L (ECF-L): A Novel Osteoclast Stimulating Factor
Y Oba, HO Chung, SJ Choi, GD Roodman
Journal of Bone and Mineral Research 2003
Regulation of osteoclast apoptosis by ubiquitylation of proapoptotic BH3-only Bcl-2 family member Bim
T Akiyama
The EMBO Journal 2003
Mechanisms balancing skeletal matrix synthesis and degradation
HC Blair, M Zaidi, PH Schlesinger
Biochemical Journal 2002
Life is short, art long. Bcl-2 and osteoclast survival
H Glantschnig, AA Reszka
BoneKEy-Osteovision 2002
ADAM8: A Novel Osteoclast Stimulating Factor
SJ Choi, JH Han, GD Roodman
Journal of Bone and Mineral Research 2001
The Microphthalmia Transcription Factor Regulates Expression of the Tartrate-Resistant Acid Phosphatase Gene During Terminal Differentiation of Osteoclasts
A Luchin, G Purdom, K Murphy, MY Clark, N Angel, AI Cassady, DA Hume, MC Ostrowski
Journal of Bone and Mineral Research 2000
CFU-GM-Derived Cells Form Osteoclasts at a Very High Efficiency
C Menaa, N Kurihara, GD Roodman
Biochemical and Biophysical Research Communications 2000
Each Venture Is a New Beginning
MK Drezner
Journal of Bone and Mineral Research 2000
Transgenic Mice Overexpressing Tartrate-Resistant Acid Phosphatase Exhibit an Increased Rate of Bone Turnover
NZ Angel, N Walsh, MR Forwood, MC Ostrowski, AI Cassady, DA Hume
Journal of Bone and Mineral Research 2000
Structure, function, and regulation of tartrate-resistant acid phosphatase
GW Oddie, G Schenk, NZ Angel, N Walsh, LW Guddat, J Jersey, AI Cassady, SE Hamilton, DA Hume
Bone 2000
Rapid Screening Method for Osteoclast Differentiation in Vitro That Measures Tartrate-resistant Acid Phosphatase 5b Activity Secreted into the Culture Medium
SL Alatalo, JM Halleen, TA Hentunen, J Mönkkönen, HK Väänänen
Clinical chemistry 2000
Annexin II increases osteoclast formation by stimulating the proliferation of osteoclast precursors in human marrow cultures
C Menaa, RD Devlin, SV Reddy, Y Gazitt, SJ Choi, GD Roodman
Journal of Clinical Investigation 1999
Cell biology of the osteoclast
GD Roodman
Experimental Hematology 1999
A putative role for c-Fos in the pathophysiology of paget's disease
KE Beedles, PT Sharpe, EF Wagner, AE Grigoriadis
Journal of Bone and Mineral Research 1999
Characterization of Immortalized Osteoclast Precursors Developed from Mice Transgenic for Both bcl-X L and Simian Virus 40 Large T Antigen 1
TA Hentunen, SH Jackson, H Chung, SV Reddy, J Lorenzo, SJ Choi, GD Roodman
Endocrinology 1999
Commitment and differentiation of stem cells to the osteoclast lineage
SI Hayashi, T Yamane, A Miyamoto, H Hemmi, H Tagaya, Y Tanio, H Kanda, H Yamazaki, T Kunisada
Biochemistry and Cell Biology 1998

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 1 patents
12 readers on Mendeley
See more details